Literature DB >> 23366248

IpsiHand Bravo: an improved EEG-based brain-computer interface for hand motor control rehabilitation.

Charles Damian Holmes1, Mark Wronkiewicz, Thane Somers, Jenny Liu, Elizabeth Russell, DoHyun Kim, Colleen Rhoades, Jason Dunkley, David Bundy, Elad Galboa, Eric Leuthardt.   

Abstract

Stroke and other nervous system injuries can damage or destroy hand motor control and greatly upset daily activities. Brain computer interfaces (BCIs) represent an emerging technology that can bypass damaged nerves to restore basic motor function and provide more effective rehabilitation. A wireless BCI system was implemented to realize these goals using electroencephalographic brain signals, machine learning techniques, and a custom designed orthosis. The IpsiHand Bravo BCI system is designed to reach a large demographic by using non-traditional brain signals and improving on past BCI system pitfalls.

Entities:  

Mesh:

Year:  2012        PMID: 23366248     DOI: 10.1109/EMBC.2012.6346287

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  3 in total

Review 1.  A structured overview of trends and technologies used in dynamic hand orthoses.

Authors:  Ronald A Bos; Claudia J W Haarman; Teun Stortelder; Kostas Nizamis; Just L Herder; Arno H A Stienen; Dick H Plettenburg
Journal:  J Neuroeng Rehabil       Date:  2016-06-29       Impact factor: 4.262

2.  Fast Recognition of BCI-Inefficient Users Using Physiological Features from EEG Signals: A Screening Study of Stroke Patients.

Authors:  Xiaokang Shu; Shugeng Chen; Lin Yao; Xinjun Sheng; Dingguo Zhang; Ning Jiang; Jie Jia; Xiangyang Zhu
Journal:  Front Neurosci       Date:  2018-02-21       Impact factor: 4.677

3.  Brain-computer interface robotics for hand rehabilitation after stroke: a systematic review.

Authors:  Paul Dominick E Baniqued; Emily C Stanyer; Muhammad Awais; Ali Alazmani; Andrew E Jackson; Mark A Mon-Williams; Faisal Mushtaq; Raymond J Holt
Journal:  J Neuroeng Rehabil       Date:  2021-01-23       Impact factor: 4.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.